Literature DB >> 1546916

Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome.

K Cheshire1, H Engleman, I Deary, C Shapiro, N J Douglas.   

Abstract

Patients with sleep apnea/hypopnea syndrome commonly demonstrate impaired daytime performance. In a prospective study, 29 patients with sleep apnea/hypopnea syndrome were assessed polysomnographically to determine the relationship of cognitive performance and daytime sleepiness with sleep disruption, hypoxemia, and mood. Deterioration of cognitive performance correlated significantly with increasing severity of nocturnal breathing irregularity, magnitude of nocturnal hypoxemia, and extent of sleep disruption. Multiple regression analysis identified frequency of apneas plus hypopneas and of arousal and the extent of nocturnal hypoxemia as the variables most strongly associated with cognitive deficits. Anxiety and depression also contributed to this impairment. Objective daytime sleepiness was not significantly associated with nocturnal variables. This study showed that the frequency of breathing irregularities and the extent of both sleep disruption and nocturnal hypoxemia are important in determining daytime function in patients with sleep apnea/hypopnea syndrome. All of these factors should be considered when deciding which patients require treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546916

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  69 in total

Review 1.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

2.  Pulse wave amplitude drops during sleep are reliable surrogate markers of changes in cortical activity.

Authors:  Alexandre Delessert; Fabrice Espa; Andrea Rossetti; Gilles Lavigne; Mehdi Tafti; Raphael Heinzer
Journal:  Sleep       Date:  2010-12       Impact factor: 5.849

Review 3.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

4.  Elevated posture for the management of obstructive sleep apnea.

Authors:  Margot A Skinner; Ruth N Kingshott; David R Jones; Sean D R Homan; D Robin Taylor
Journal:  Sleep Breath       Date:  2004-12       Impact factor: 2.816

5.  Caffeine intake is independently associated with neuropsychological performance in patients with obstructive sleep apnea.

Authors:  Daniel Norman; Wayne A Bardwell; Jose S Loredo; Sonia Ancoli-Israel; Robert K Heaton; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2008-08       Impact factor: 2.816

6.  The Effect of Body Position on Physiological Factors that Contribute to Obstructive Sleep Apnea.

Authors:  Simon A Joosten; Bradley A Edwards; Andrew Wellman; Anthony Turton; Elizabeth M Skuza; Philip J Berger; Garun S Hamilton
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

7.  Relationship between obstructive sleep apnea severity and brain activation during a sustained attention task.

Authors:  Liat Ayalon; Sonia Ancoli-Israel; Allison A Aka; Benjamin S McKenna; Sean P A Drummond
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

8.  Relationship between sleep, sleep apnea, and neuropsychological function in children with Down syndrome.

Authors:  Lee J Brooks; Molly N Olsen; Ann Mary Bacevice; Andrea Beebe; Sofia Konstantinopoulou; H Gerry Taylor
Journal:  Sleep Breath       Date:  2014-05-07       Impact factor: 2.816

9.  Nonparametric Signal Extraction and Measurement Error in the Analysis of Electroencephalographic Activity During Sleep.

Authors:  Ciprian M Crainiceanu; Brian S Caffo; Chong-Zhi Di; Naresh M Punjabi
Journal:  J Am Stat Assoc       Date:  2009-06-01       Impact factor: 5.033

10.  Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; S E Martin; R N Kingshott; T W Mackay; I J Deary; N J Douglas
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.